Outcomes and factors affecting mortality and successful tracing among patients lost to follow-up from antiretroviral therapy in Pawi Hospital, Northwest Ethiopia

Table 4 Factors associated with mortality of adult HIV-positive patients LTFU

Variable	Outcomes number (%)		Crude OR (95% CI)	Adjusted OR (95% CI)	p value
Variable	Deceased	Alive	Crude OR (95% CI)	Adjusted OR (95% CI)	p value
Age category
18–28 years	17 (29.8)	75 (39.1)	1	1
29–40 years	23 (40.4)	78 (40.6)	0.77 (0.38,1.55)	0.78 (0.38–1.60)	0.491
> 40 years	17 (29.8)	39 (20.3)	0.52 (0.24,1.13)	0.54 (0.24–1.20)	0.129
CPT
Not received	11 (19.3)	80 (41.7)	2.98 (1.46,6.12)	2.59 (1.22–5.59)	0.013*
Received	46 (80.7)	112 (58.3)	1	1	1
Tracing methods
Phone	16 (28.1)	79 (41.1)	1.79 (0.94,3.42)	1.53 (0.78–3.02)	0.217
Field work	41 (71.9)	113 (58.9)	1	1	1
Clinical stage
I/II	16 (28.1)	64 (33.3)	1	1
III	22 (38.6)	85 (44.3)	0.97 (0.45,1.99)	1.03 (0.49–2.17)	0.932
IV	19 (33.3)	43 (22.4)	0.57 (0.26,1.22)	0.69 (0.31–1.54)	0.369
Follow-up time
< 12 months	40 (70.2)	120 (62.5)	1	1
> 12 months	17 (29.8)	72 (37.5)	1.41 (0.75,2.67)	1.57 (0.77–2.94)	0.231

ISSN: 1349-4147